Assignee
BERNER BRET
US14 patents
Top patents by PatentIndex Score
US8329215B2Dec 11, 2012
Shell and core dosage form approaching zero-order drug release
BERNER BRET32 citations95
US8192756B2Jun 5, 2012
Gastric retained gabapentin dosage form
BERNER BRET29 citations95
US8119166B2Feb 21, 2012
Methods of treatment using a gastric retained gabapentin dosage
BERNER BRET10 citations92
US9980903B2May 29, 2018
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
BERNER BRET14 citations84
US9000046B2Apr 7, 2015
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
BERNER BRET8 citations82
US9017667B2Apr 28, 2015
Dosage forms that facilitate rapid activation of barley protease zymogen
BERNER BRET2 citations63
US8475813B2Jul 2, 2013
Methods of treatment using a gastric retained gabapentin dosage
BERNER BRET1 citations63
US8440232B2May 14, 2013
Methods of treatment using a gastric retained gabapentin dosage
BERNER BRET1 citations62
US8409613B2Apr 2, 2013
Gastric retained gabapentin dosage form
BERNER BRET1 citations62
US8231905B2Jul 31, 2012
Gastric retained gabapentin dosage form
BERNER BRET1 citations62
US8329750B2Dec 11, 2012
Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form
BERNER BRET2 citations56
US8529955B2Sep 10, 2013
Methods of treatment using a gastric retained gabapentin dosage
BERNER BRET0 citations51
US8333991B2Dec 18, 2012
Gastric retained gabapentin dosage form
BERNER BRET0 citations51
US8333992B2Dec 18, 2012
Gastric retained gabapentin dosage form
BERNER BRET0 citations51